HSPC111 Antibody (monoclonal) (M01)

Q9Y3C1

WB, IHC, IF, E

The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome. Butt AJ, et al. Breast Cancer Res, 2008. PMID 18373870.The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Gerhard DS, et al. Genome Res, 2004 Oct. PMID 15489334.Generation and initial analysis of more than 15, 000 full-length human and mouse cDNA sequences. Strausberg RL, et al. Proc Natl Acad Sci U S A, 2002 Dec 24. PMID 12477932.Functional proteomic analysis of human nucleolus. Scherl A, et al. Mol Biol Cell, 2002 Nov. PMID 12429849.Directed proteomic analysis of the human nucleolus. Andersen JS, et al. Curr Biol, 2002 Jan 8. PMID 11790298.

51491

Mouse monoclonal antibody raised against a full length recombinant HSPC111.

Immunofluorescence of monoclonal antibody to HSPC111 on HeLa cell. [antibody concentration 10 ug/ml]

Antibody Reactive Against Recombinant Protein.Western Blot detection against Immunogen (45.32 KDa) .

1:500~1000

WB

Immunoperoxidase of monoclonal antibody to HSPC111 on formalin-fixed paraffin-embedded human tonsil. [antibody concentration 3 ug/ml]

Detection limit for recombinant GST tagged HSPC111 is approximately 1ng/ml as a capture antibody.

BC040106

Human: ~~ Positive

NP_001243468.1; NP_001243469.1; NP_057475.2

AAH40106

NOP16 is transcriptionally regulated by c-Myc (MYC; MIM 190080), upregulated in breast cancer, and overexpression is associated with poor patient survival (Butt et al., 2008).[supplied by OMIM